# REBLOZYL
> **BLA761136** · Biologics License Application · Sponsor: CELGENE CORP · Approved 2019-11-08
## Drug
- **FDA Application Number:** BLA761136
- **Application type:** Biologics License Application
- **Brand name:** REBLOZYL
- **Generic name:** LUSPATERCEPT
- **Active ingredients:** LUSPATERCEPT-AAMT
- **Dosage form:** POWDER
- **Route:** SUBCUTANEOUS
- **Marketing status:** Prescription
- **Sponsor:** CELGENE CORP
- **Manufacturer:** Celgene Corporation
- **First approval:** 2019-11-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761136)
---
*AI Analytics · CC0 1.0*